Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - NEXGEN BIOFUELS LTD | exhibit_31-1.htm |
| 10-Q - NEXGEN BIOFUELS LTD | zk1009086.htm |
| EX-32.2 - EXHIBIT 32.2 - NEXGEN BIOFUELS LTD | exhibit_32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - NEXGEN BIOFUELS LTD | exhibit_31-2.htm |
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the accompanying Quarterly Report On Form 10-Q of Laxai Pharma, Ltd. (the "Company") for the quarter ending September 30, 2010, I, Naren Mallakunta, Chief Executive Officer of the Company hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
1. Such Quarterly Report on Form 10-Q for the quarter ending September 30, 2010, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in such Quarterly Report on Form 10-Q for the quarter ending September 30, 2010, fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: November 19, 2010 | LAXAI PHARMA, LTD. | ||
|
|
By:
|
/s/ Naren Mallakunta | |
| Naren Mallakunta | |||